SCHEMBL11829232

SCHEMBL11829232

CCCCCCN(CCCCCC)S(=O)(=O)c1cc(C(=O)O)ccc1SCc1ccc(C)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
CNR2 P34972 1/20 0.41
TAS2R14 Q9NYV8 2/20 0.40
CA12 O43570 1/20 0.40
CA2 P00918 1/20 0.40
RAB9A P51151 1/20 0.40
CA9 Q16790 1/20 0.40
SLC22A6 Q4U2R8 1/20 0.40
SLC22A8 Q8TCC7 1/20 0.40
ABCC2 Q92887 1/20 0.40
SLC22A12 Q96S37 1/20 0.40
UGT1A7 Q9HAW7 1/20 0.40
SLC22A11 Q9NSA0 1/20 0.40
RARB P10826 5/20 0.39
MAPT P10636 3/20 0.39
HTT P42858 1/20 0.39
ALDH1A1 P00352 3/20 0.39
PTGES O14684 2/20 0.39
ALOX5 P09917 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11819424 0.84 KMT2A (0.41) KMT2ASMN1; SMN2CA12CA2RAB9A
SCHEMBL11821357 0.81 CNR2 (0.48) SMN1; SMN2CNR2TAS2R14CA12CA2
SCHEMBL11815261 0.79 CNR2 (0.46) SMN1; SMN2CNR2TAS2R14CA12CA2
SCHEMBL11827334 0.79 CNR2 (0.48) SMN1; SMN2CNR2TAS2R14CA12CA2
SCHEMBL11829733 0.76 SMN1; SMN2 (0.52) KMT2ASMN1; SMN2CA12CA2RAB9A
SCHEMBL11819862 0.76 SMN1; SMN2 (0.52) KMT2ASMN1; SMN2CA12CA2RAB9A
SCHEMBL11822899 0.74 SMN1; SMN2 (0.44) KMT2ASMN1; SMN2CNR2TAS2R14CA12
SCHEMBL11822163 0.72 CA2 (0.47) KMT2ASMN1; SMN2CNR2TAS2R14CA12
SCHEMBL11818580 0.72 CA2 (0.47) KMT2ASMN1; SMN2CNR2TAS2R14CA12
SCHEMBL11816329 0.72 CNR2 (0.49) SMN1; SMN2CNR2TAS2R14CA12CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-3954994-A Intermediates for preparing hipolipemic agents and method of lowering the blood lipid level in mammals with said agents PFIZER INC. (US) 1976-05-04 US disclosed